These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 27091576)
1. Postnatal knockdown of dok-7 gene expression in mice causes structural defects in neuromuscular synapses and myasthenic pathology. Eguchi T; Tezuka T; Miyoshi S; Yamanashi Y Genes Cells; 2016 Jun; 21(6):670-6. PubMed ID: 27091576 [TBL] [Abstract][Full Text] [Related]
2. The carboxyl-terminal region of Dok-7 plays a key, but not essential, role in activation of muscle-specific receptor kinase MuSK and neuromuscular synapse formation. Ueta R; Tezuka T; Izawa Y; Miyoshi S; Nagatoishi S; Tsumoto K; Yamanashi Y J Biochem; 2017 Mar; 161(3):269-277. PubMed ID: 28069867 [TBL] [Abstract][Full Text] [Related]
3. The MuSK activator agrin has a separate role essential for postnatal maintenance of neuromuscular synapses. Tezuka T; Inoue A; Hoshi T; Weatherbee SD; Burgess RW; Ueta R; Yamanashi Y Proc Natl Acad Sci U S A; 2014 Nov; 111(46):16556-61. PubMed ID: 25368159 [TBL] [Abstract][Full Text] [Related]
5. [Molecular mechanisms underlying the formation and maintenance of neuromuscular junctions and a possible therapeutic approach.]. Eguchi T; Tezuka T; Miyoshi S; Yamanashi Y Clin Calcium; 2017; 27(3):413-419. PubMed ID: 28232656 [TBL] [Abstract][Full Text] [Related]
6. Dok-7/MuSK signaling and a congenital myasthenic syndrome. Yamanashi Y; Higuch O; Beeson D Acta Myol; 2008 Jul; 27(1):25-9. PubMed ID: 19108574 [TBL] [Abstract][Full Text] [Related]
7. Overexpression of Dok-7 in skeletal muscle enhances neuromuscular transmission with structural alterations of neuromuscular junctions: Implications in robustness of neuromuscular transmission. Eguchi T; Tezuka T; Fukudome T; Watanabe Y; Sagara H; Yamanashi Y Biochem Biophys Res Commun; 2020 Feb; 523(1):214-219. PubMed ID: 31848047 [TBL] [Abstract][Full Text] [Related]
8. Dok-7 activates the muscle receptor kinase MuSK and shapes synapse formation. Inoue A; Setoguchi K; Matsubara Y; Okada K; Sato N; Iwakura Y; Higuchi O; Yamanashi Y Sci Signal; 2009 Feb; 2(59):ra7. PubMed ID: 19244212 [TBL] [Abstract][Full Text] [Related]
9. Neuromuscular disease. DOK7 gene therapy benefits mouse models of diseases characterized by defects in the neuromuscular junction. Arimura S; Okada T; Tezuka T; Chiyo T; Kasahara Y; Yoshimura T; Motomura M; Yoshida N; Beeson D; Takeda S; Yamanashi Y Science; 2014 Sep; 345(6203):1505-8. PubMed ID: 25237101 [TBL] [Abstract][Full Text] [Related]
10. Dok-7 promotes slow muscle integrity as well as neuromuscular junction formation in a zebrafish model of congenital myasthenic syndromes. Müller JS; Jepson CD; Laval SH; Bushby K; Straub V; Lochmüller H Hum Mol Genet; 2010 May; 19(9):1726-40. PubMed ID: 20147321 [TBL] [Abstract][Full Text] [Related]
11. The transcription factor Sp1 plays a crucial role in dok-7 gene expression. Hamuro J; Hishida Y; Higuchi O; Yamanashi Y Biochem Biophys Res Commun; 2011 May; 408(2):293-9. PubMed ID: 21504746 [TBL] [Abstract][Full Text] [Related]
12. [Molecular mechanisms underlying the formation of neuromuscular junction]. Higuchi O; Yamanashi Y Brain Nerve; 2011 Jul; 63(7):649-55. PubMed ID: 21747134 [TBL] [Abstract][Full Text] [Related]
13. Specific binding of collagen Q to the neuromuscular junction is exploited to cure congenital myasthenia and to explore bases of myasthenia gravis. Ohno K; Ito M; Kawakami Y; Krejci E; Engel AG Chem Biol Interact; 2013 Mar; 203(1):335-40. PubMed ID: 22981737 [TBL] [Abstract][Full Text] [Related]